New developments in the pathogenesis, therapeutic targeting, and treatment of pediatric medulloblastoma

FY Fang, JS Rosenblum, WS Ho, JD Heiss - Cancers, 2022 - mdpi.com
Simple Summary Medulloblastoma is the most common pediatric brain tumor, comprising
one-third of all pediatric brain tumors, and originating in the posterior fossa of the brain. The …

Superenhancers as master gene regulators and novel therapeutic targets in brain tumors

HH Zhuang, Q Qu, XQ Teng, YH Dai, J Qu - Experimental & Molecular …, 2023 - nature.com
Transcriptional deregulation, a cancer cell hallmark, is driven by epigenetic abnormalities in
the majority of brain tumors, including adult glioblastoma and pediatric brain tumors …

O-GlcNAcylation promotes cerebellum development and medulloblastoma oncogenesis via SHH signaling

L Chen, Y Li, Z Song, S Xue, F Liu… - Proceedings of the …, 2022 - National Acad Sciences
Sonic hedgehog (Shh) signaling plays a critical role in regulating cerebellum development
by maintaining the physiological proliferation of granule neuron precursors (GNPs), and its …

Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II …

AS Levy, M Krailo, S Chi, D Villaluna… - Pediatric blood & …, 2021 - Wiley Online Library
Background: Approximately 30% of children with medulloblastoma (MB) experience
recurrence, which is usually incurable. This study compared the overall survival (OS) of …

Exploring the molecular complexity of medulloblastoma: implications for diagnosis and treatment

JS Rechberger, SA Toll, WJF Vanbilloen, DJ Daniels… - Diagnostics, 2023 - mdpi.com
Medulloblastoma is the most common malignant brain tumor in children. Over the last few
decades, significant progress has been made in revealing the key molecular underpinnings …

FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis

H Zhou, YX Wang, M Wu, X Lan, D Xiang… - The Journal of …, 2024 - Wiley Online Library
Radiotherapy is one of the standard therapeutic regimens for medulloblastoma (MB). Tumor
cells utilize DNA damage repair (DDR) mechanisms to survive and develop resistance …

Risk factors for survival in patients with medulloblastoma: a systematic review and meta-analysis

Y Liu, B Xiao, S Li, J Liu - Frontiers in Oncology, 2022 - frontiersin.org
Background Conventional parameters show limited and unreliable correlations with
medulloblastoma prognosis. Aim To evaluate the factors influencing overall survival (OS) …

Cross-translational models of late-onset cognitive sequelae and their treatment in pediatric brain tumor survivors

NZ Al Dahhan, E Cox, BJ Nieman, DJ Mabbott - Neuron, 2022 - cell.com
Pediatric brain tumor treatments have a high success rate, but survivors are at risk of
cognitive sequelae that impact long-term quality of life. We summarize recent clinical and …

Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma

E Martell, H Kuzmychova, E Kaul, H Senthil… - Nature …, 2023 - nature.com
Abstract Group 3 medulloblastoma (G3 MB) carries the worst prognosis of all MB subgroups.
MYC oncoprotein is elevated in G3 MB tumors; however, the mechanisms that support MYC …

DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas

A Korshunov, F Sahm, O Zheludkova… - Neuro …, 2019 - academic.oup.com
Background Wingless-activated medulloblastoma (WNT MB) represents a well-
characterized molecular variant accounting for 10–15% of all MB and is associated with a …